-
CEPI, VBI Vaccines Collaborate To Develop COVID-19 Vaccine Candidates Against Variants
Wednesday, March 10, 2021 - 10:26am | 263Read More...The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines Inc (NASDAQ: VBIV) entered into a partnership for the development of VBI's enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants, including the South African B.1....
-
Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development
Tuesday, May 12, 2020 - 2:08pm | 754Read More...Novavax, Inc. (NASDAQ: NVAX) announced Monday after the close an award of an incremental $384 million in funding by the Coalition for Epidemic Preparedness Innovations alongside forecast-beating first-quarter results. The Novavax Analysts H.C. Wainwright analyst Vernon Bernardino reiterated a Buy...
-
Novavax Receives $384M For Coronavirus Vaccine Program In CEPI's 'Single Biggest Investment' To Date
Monday, May 11, 2020 - 5:41pm | 325Read More...Novavax, Inc. (NASDAQ: NVAX), which is in the race for developing a vaccine for the new coronavirus, announced Monday afternoon new funding for its vaccine program. The company said the Coalition for Epidemic Preparedness Innovations, or CEPI, will invest up to $384 million, on top of $4 million it...
